The first-ever publicly traded cannabis company in the United States, Medical Marijuana Inc announced today the Japanese division of its subsidiary Kannaway® reached record-high sales in Company history during July 2020. According to Prohibition Partners, China and Japan present a large opportunity for CBD products as they collectively account for about 90 percent of Asia’s CBD market, which anticipated to be worth $5.8 billion by 2024. Kannaway officials remarked consumer demand in Japan and China continue to show an exciting increase in interest for cannabidiol (CBD) product globally.

– Mmp News Author, Medical Marijuana Program Connection, 08/13/2020 10:45:07 AM

Open article: